Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib + Carboplatin in Recurrent High-Grade Gliomas
NCT00995007Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2009
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in glioma, sponsored by National Cancer Institute. Started Sep 2009; status: completed.
02
Drugs
vandetanib
03
Conditions
glioma
Beyond the preview
Go deeper on NCT00995007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995007.